Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

LncRNA FGD5-AS1 promotes the malignant phenotypes of ovarian cancer cells via targeting miR-142-5p
Aichen Zhang, Kun Wang, Xiaochun Sun, et al.
APOPTOSIS (2021) Vol. 26, Iss. 5-6, pp. 348-360
Closed Access | Times Cited: 17

Showing 17 citing articles:

MicroRNAs as regulators of immune checkpoints in cancer immunotherapy: targeting PD-1/PD-L1 and CTLA-4 pathways
Arefeh Zabeti Touchaei, Sogand Vahidi
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 28
PD-L1: expression regulation
Yujie Zhou, Guoli Li, Jiyin Wang, et al.
Blood Science (2023) Vol. 5, Iss. 2, pp. 77-91
Open Access | Times Cited: 26
Current understanding of functional peptides encoded by lncRNA in cancer
Hua Tian, Lu Tang, Zihan Yang, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 9
miR‐142‐3p/5p role in cancer: From epigenetic regulation to immunomodulation
Parisa Zareifar, Hani Moslem Ahmed, Pouya Ghaderi, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 2
Closed Access | Times Cited: 8
M2 macrophage-derived exosomal circTMCO3 acts through miR-515-5p and ITGA8 to enhance malignancy in ovarian cancer
Xiaomin Ran, Juan Yang, Ziyi Wang, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 5
Pharmacological targeting of PD-L1/PD-1 signaling in gynecological cancers
Ammad Ahmad Farooqı, Gürkan Özbey, Sundas Fayyaz, et al.
Postępy Higieny i Medycyny Doświadczalnej (2025) Vol. 79, Iss. 1, pp. 25-34
Open Access
Targeting PD-1/PD-L1 axis as new horizon for ovarian cancer therapy
Elina Khatoon, Parama Dey, Aviral Kumar, et al.
Life Sciences (2022) Vol. 306, pp. 120827-120827
Closed Access | Times Cited: 19
Nanotechnology for boosting ovarian cancer immunotherapy
Prabhjot Kaur, Santosh Kumar Singh, Manoj K. Mishra, et al.
Journal of Ovarian Research (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 3
The role of long non-coding RNA FGD5-AS1 in cancer
Na He, Linbiao Xiang, Lei Chen, et al.
Bioengineered (2022) Vol. 13, Iss. 4, pp. 11026-11041
Open Access | Times Cited: 17
The Features of Immune Checkpoint Gene Regulation by microRNA in Cancer
Ф. М. Кипкеева, Tatyana Muzaffarova, А. А. Коротаева, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9324-9324
Open Access | Times Cited: 11
Autophagy-related IFNG is a prognostic and immunochemotherapeutic biomarker of COAD patients
Taohua Yue, Yunlong Cai, Jing Zhu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
LncRNA FGD5‐AS1 enhances the proliferation and stemness of hepatocellular carcinoma cells through targeting miR‐223 and regulating the expression of ECT2 and FAT1
Chen‐Kun He, Zeng‐Bo Li, Da Yi, et al.
Hepatology Research (2022) Vol. 52, Iss. 7, pp. 614-629
Closed Access | Times Cited: 10
Identification of lncRNAs Deregulated in Epithelial Ovarian Cancer Based on a Gene Expression Profiling Meta-Analysis
Martín Salamini-Montemurri, Mónica Lamas‐Maceiras, Lidia Lorenzo-Catoira, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10798-10798
Open Access | Times Cited: 4
FGD5-AS1/miR-5590-3p/PINK1 induces Lenvatinib resistance in hepatocellular carcinoma
Meifang Song, Luyuan Ma, Chuan Shen, et al.
Cellular Signalling (2023) Vol. 111, pp. 110828-110828
Closed Access | Times Cited: 4
Maternal embryonic leucine zipper kinase serves as a potential prognostic marker and leads to sorafenib chemoresistance modified by miR-142-5p in hepatocellular carcinoma
Hualei Li, Ling Gai, Zhimei Wu, et al.
Molecular Biology Reports (2022) Vol. 49, Iss. 4, pp. 3015-3024
Closed Access | Times Cited: 5
The emerging roles of LINC00511 in breast cancer development and therapy
Lifeng Zhao, S. Biswas, Yepeng Li, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
The prognostic significance of lncRNA FGD5-AS1 in various malignancies: a meta-analysis
Hongyan Lei, Tao Ye, Jiaxin Sun, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Abnormal Expression of Long Non-Coding RNA FGD5-AS1 Affects the Development of Ovarian Cancer Through Regulating miR-107/RBBP6 Axis
Wen Zhang, Jianguo Shi, Guo-Yan Liu
The Chinese Journal of Physiology (2023) Vol. 66, Iss. 3, pp. 171-180
Open Access
Page 1

Scroll to top